Wednesday, 17 November 2021 Reading time : 3 minutes

Headquarters: Growth and satisfied investors
Medical technology, energy and automation technology are some of the many promising growth sectors in which the traditional German corporation Siemens is represented - in quite a few of them as the industry leader.

Today, the conglomerate is divided into a portfolio of independent companies operating in different sectors, with the parent company holding the majority of shares in each.

Its strategy seems to be working well. Investors are rewarded not only with outperformance versus the benchmark - the stock achieved a 1-year performance of almost 39%, while the DAX index gained almost 24% in the same period) - but also with steadily growing dividends: In 2010, Siemens paid EUR 2.70 per share, and in 2021 it will pay EUR 4, almost one and a half times as much.

Siemens Healthineers: Exceeding expectations
Siemens Healthineers combines all the companies in the medical technology sector of Siemens AG. With over 60,000 employees and around EUR 18 billion in sales, the group is one of the world's largest manufacturers in the sector. The share price performance impressively shows that Med Tech is in demand among investors; in 2021, it gained almost 68%. Just this morning, the company also released new growth targets; earnings growth is expected to rise to between 6% and 8% (previously 5%) and earnings per share to 15% from 10%. The stock has responded with a price increase.

Siemens Energy: Broad technology portfolio
Not only the generation of energy, but also its transmission is a core element in supplying energy to industry and the population. In the fourth quarter, new orders at Siemens Energy - specializing in both topics - rose by more than 30%; this development should result in rising sales, higher profits and better dividends.

The shares of the three companies together make up 12% of the DAX Index weights, demonstrating the size and importance of the group. The analyst consensus is to outperform the market.

---

Barrier Reverse Convertible on Siemens, Siemens Healthineers and Siemens Energy (EUR / CHF)

• 7.5% / 7.25% coupon p.a.
• Defensive barrier at 60%
• 18 months maturity
• Subscription period until November 22, 2021
• Termsheet EUR
• Termsheet CHF

Callable BRC on Siemens, Siemens Healthineers and Siemens Energy (EUR / CHF)

• 9% / 8.75% coupon p.a.
• Defensive barrier at 60%
• 18 months maturity
• Subscription period until November 22, 2021
• Termsheet EUR
• Termsheet CHF

Callable BRC on Siemens (EUR / CHF)

• 6% / 5.75% coupon p.a.
• Barrier at 70%
• 18 months maturity
• Subscription period until November 24, 2021
• Termsheet EUR
• Termsheet CHF

Discover our leverage products on Siemens

All data indicative

 

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.